Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success
Author:
Affiliation:
1. Biohaven Pharmaceuticals Inc., 215 Church Street, New Haven, Connecticut 06510, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01810
Reference153 articles.
1. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
2. Functional role of perivascular peptides in the control of cerebral circulation
3. CGRP as the target of new migraine therapies — successful translation from bench to clinic
4. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate
5. Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Graphene as a potential treatment for acute migraine: A computational study;Materials Today Communications;2024-03
2. Synthesis and clinical application of new drugs approved by FDA in 2023;European Journal of Medicinal Chemistry;2024-02
3. A review: FDA-approved fluorine-containing small molecules from 2015 to 2022;European Journal of Medicinal Chemistry;2023-11
4. Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research;Trends in Pharmacological Sciences;2023-10
5. Novel peptide calcitonin gene-related peptide antagonists for migraine therapy;Journal of Pharmacy and Pharmacology;2023-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3